1 HS CLASSIFICATION OF INN PRODUCTS (INN LIST 111) SH

CONTRACTING PARTY/
PARTIE CONTRACTANTE
RESPONSIBLE FOR HS MATTERS IN
YOUR ADMINISTRATION/ RESPONSABLE
DU SH DANS VOTRE ADMINISTRATION
ADDRESS/
ADRESSE
DATE AND SIGN/
DATE ET SIGNATURE
HS CLASSIFICATION OF INN PRODUCTS (INN LIST 111)
SH CLASSEMENT DES PRODUITS DCI (LISTE DE DCI 111)
INN/
DCI*
HS Classification proposed by the
Secretariat/
Classement dans le SH proposé par le
Secrétariat
abrilumab/
abrilumab
3002.10
Immunological product (MAB)/
Produit immunologique (MAB)
acumapimod/
acumapimod
2933.19
Pyrazole ring/Cycle Pyrazole
Classification and Comments by Administrations /
Classement et observations des administrations
1
albenatide/
albénatide
asvasiran/
asvasiran
azeliragon/
azéliragon
basmisanil/
basimisanil
beclavubir/
béclavubir
2933.29
Imidazole ring/Cycle imidazole
begelomab/
bégélomab
3002.10
Immunological product (MAB)/
Produit immunologique (MAB)
benzhydrocodone/
benzhydrocodone
bradanicline/
bradanicline
briciclib/
briciclib
2934.99
N,O-ring/ N,O-cycle
brontictuzumab/
brontictuzumab
3002.10
Immunological product (MAB)/
Produit immunologique (MAB)
butylphthalide/
butylphthalide
cabotegravir/
cabotégravir
capmatinib/
capmatinib
cefilavancin/
céfilavancine
2932.20
Lactone/Lactone
2934.99
S-ring/S-cycle
2934.99
RNA/ARN
2934.99
N,O-ring/ N,O-cycle
2935.00
Sulphonamide/Sulfonamide
2934.99
N,O-ring/ N,O-cycle
2930.90
Sulphone/Sulfone
2934.99
N,O-ring/ N,O-cycle
2933.99
Other N-rings/ Autres N-cycles
2941.90
Other antibiotics/ Autres antibiotiques
2
cerdulatinib/
cerdulatinib
cerliponase alfa/
cerliponase alfa
dagrocorat/
dagrocorat
dalatazide/
dalatazide
dapaconazole/
dapaconazole
defactinib/
défactinib
denintuzumab
mafodotine/
dénintuzumab
mafodotine
dianhydrogalactitol/
dianhydrogalactitol
diclofenac
etalhyaluronate/
étalhyaluronate de
diclofénac
2935.00
Sulphonamide/Sulfonamide
3507.90
Enzyme/Enzyme
2933.39
Pyridine ring/ Cycle pyridine
2934.99
S-ring/S-cycle
2933.29
Imidazole ring/Cycle imidazole
2935.00
Sulphonamide/Sulfonamide
3002.10
Immunological product (MAB)/
Produit immunologique (MAB)
2910.90
Epoxide/Epoxide
3913.90
Natural polymer. More information is needed/
Poymére naturelle. Information additionnelle
souhaitée.
diridavumab/
diridavumab
3002.10
Immunological product (MAB)/
Produit immunologique (MAB)
éflapegastrim/
éflapégastrim
3002.10
Colony stimulating factor
Facteur de stimulation des colonies
efmoroctocog alfa/
efmoroctocog alfa
3002.10
Blood coagulation factor
Facteur de coagulation du sang
3
emactuzumab/
émactuzumab
3002.10
Immunological product (MAB)/
Produit immunologique (MAB)
emibetuzumab/
emibetuzumab
3002.10
Immunological product (MAB)/
Produit immunologique (MAB)
enadenotucirev/
énadénotucirev
encenicline/
encénicline
2934.99
Nucleotides/Nucléotides
esuberaprost/
ésubéraprost
2932.99
O-ring with the stem “prost” (2937.50 ?) /
O-cycle avec le suffixe “prost” (2937.50 ?)
evofosfamide/
évofosfamide
ferric maltol/
maltol ferrique
2933.29
Imidazole ring/Cycle imidazole
filociclovir/
filociclovir
2933.59
Pyrimidine ring. See E.N to sub. 2933.79/
o
Cycle pyrimidine Voir N.E au N 2933.79
firivumab/
firivumab
3002.10
Immunological product (MAB)/
Produit immunologique (MAB)
fosdagrocorat/
fosdagrocorat
funapide/
funapide
furaprevir/
furaprévir
2933.39
Pyridine ring/ Cycle pyridine
2934.99
N,S-ring/N,S-cycle
2932.99
O-ring /O-cycle
2934.99
N,O-ring/ N,O-cycle
2935.00
Sulphonamide/Sulfonamide
4
gedatolisib/
gedatolisib
glasdegib/
glasdégib
Idasanutlin/
idasanutline
2934.99
N,O-ring/ N,O-cycle
2933.39
Pyridine ring/ Cycle pyridine
2933.99
Other N-rings/ Autres N-cycles
imalumab/
imalumab
3002.10
Immunological product (MAB)/
Produit immunologique (MAB)
indoximod/
indoximod
irbinitinib/
irbinitinib
lemborexant/
lemborexant
2933.99
Other N-rings/ Autres N-cycles
2934.99
N,O-ring/ N,O-cycle
2933.59
Pyrimidine ring/ Cycle pyrimidine
lenzilumab/
lenzilumab
3002.10
Immunological product (MAB)/
Produit immunologique (MAB)
lonoctocog alfa
lonoctocog alfa
3002.10
Blood coagulation factor
Facteur de coagulation du sang
lulizumab pegol/
lulizumab pégol
3002.10
Pegylated immunological product (MAB)/
Produit immunologique pegylé (MAB)
lumretuzumbab/
lumrétuzumab
3002.10
Immunological product (MAB)/
Produit immunologique (MAB)
merotocin/
mérotocine
2934.99
S-ring/ S-cycle
5
mibenratide/
mibenratide
modimelanotide/
modimélanotide
mongersen/
mongersen
napabucasin/
napabucasine
odalasvir/
odalasvir
olipudase alfa/
olipudase alfa
omipalisib/
omipalisib
orilotimod/
orilotimod
2934.99
S-ring/ S-cycle
2933.49
Quinoline (Trp)/Quinoléine (Trp)
2934.99
Nucleotides/Nucléotides
2932.99
O-ring, fused furan/O-cycle furanne condensé
2933.99
Other N-rings/ Autres N-cycles
2934.99 or/ou 3507.90
Enzyme or DNA/Enzyme ou ADN
2935.00
Sulphonamide/Sulfonamide
2933.99
Other N-rings/ Autres N-cycles
pasotuxizumab/
pasotuxizumab
3002.10
Immunological product (MAB)/
Produit immunologique (MAB)
peficitinib/
péficitinib
2933.99
Other N-rings/ Autres N-cycles
pegargiminase/
pégargiminase
3002.10 or/ou 3507.90
st
E.N to heading 30.02, Part (C) (1), 1 par./
o
er
N.E au N 30.02, Partie C) 1), 1 par.
pegcrisantaspase/
pegcrisantaspase
3002.10 or/ou 3507.90
st
E.N to heading 30.02, Part (C) (1), 1 par./
o
er
N.E au N 30.02, Partie C) 1), 1 par
pegvaliase/
pegavaliase
polmacoxib/
polmacoxib
3507.90
Enzyme/ Enzyme
2935.00
Sulphonamide/Sulfonamide
6
presatovir/
présatovir
rabacfosadine/
rabacfosadine
rapastinel/
rapastinel
relenopride/
rélénopride
2935.00
Sulphonamide/Sulfonamide
2933.59
Pyrimidine ring/ Cycle pyrimidine
2933.99
Other N-rings/ Autres N-cycles
2933.39
Pyridine ring/ Cycle pyridine
reveglucosidase alfa/
révéglucosidase alfa
3002.10 or/ou 3507.90
st
E.N to heading 30.02, Part (C) (1), 1 par./
o
er
N.E au N 30.02, Partie C) 1), 1 par
revusiran/
révusiran
ribociclib/
ribociclib
rimiducid/
rimiducid
2934.99
Nucleotides/Nucléotides
2933.59
Pyrimidine ring/ Cycle pyrimidine
rociletinib/
rocilétinib
2933.59
Pyrimidine, piperazine ring/
Cycle pyrimidine, pipérazine
rurioctocog alfa pegol/
rurioctocog alfa pégol
3002.10
Blood coagulation factor
Facteur de coagulation du sang
sarolaner/
sarolaner
savolitinib/
savolitinib
2934.99
N,O-ring/ N,O-cycle
2933.39
Pyridine ring/ Cycle pyridine
2933.79
Pyrazole ring/ Cycle pirazole
7
sembragiline/
sembragiline
tenofovir alafenamide/
ténofovir alafénamide
2933.79
Lactam/Lactam
2933.59
Pyrimidine ring/Cycle pyrimidine
tepotinib/
tepotinib
2933.59
Pyrimidine ring. See E.N to sub. 2933.79/
o
Cycle pyrimidine Voir N.E au N 2933.79
tradipitant/
tradipitant
2933.39
Pyridine ring/ Cycle pyridine
transcrocetin/
transcrocétine
2917.19
Acyclic polycarboxilic acid/
Acide polycarboxilique acyclique
ulixertinib/
ulixertinib
uprosertib/
uprosertib
2933.39
Pyridine ring/ Cycle pyridine
vanucizumab/
vanucizumab
3002.10
Immunological product (MAB)/
Produit immunologique (MAB)
varlilumab/
varlilumab
3002.10
Immunological product (MAB)/
Produit immunologique (MAB)
velpatasvir/
velpatasvir
venetoclax/
vénétoclax
2934.99
N,O-ring/ N,O-cycle
2934.99
N,O-ring/ N,O-cycle
2935.00
Sulphonamide/Sulfonamide
8
verinurad/
vérinurad
2933.39
Pyridine ring/ Cycle pyridine
vonapanitase/
vonapanitase
3002.10 or/ou 3507.90
st
E.N to heading 30.02, Part (C) (1), 1 par./
o
er
N.E au N 30.02, Partie C) 1), 1 par
3002.10 or/ou 3507.90
st
E.N to heading 30.02, Part (C) (1), 1 par./
o
er
N.E au N 30.02, Partie C) 1), 1 par
* “The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances 2013” published by the WHO
(Stem Book 2013). http://www.who.int/medicines/services/inn/StemBook_2013_Final.pdf?ua=1
vorhyaluronidase alfa/
vorhyaluronidase alfa
9